Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Chromatin Remodeling and Cancer, Renal and related cancers, Cancer Genomics and Diagnostics, and Bladder and Urothelial Cancer Treatments.
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials
TAZNI: A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors.
Genetics of ABCB1 in Cancer
Children's Oncology Group's 2023 blueprint for research: Renal tumors
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children’s Oncology Group AREN18B5-Q
Hallmark discoveries in the biology of Wilms tumour
SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities
SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization
Progress Update in Pediatric Renal Tumors
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer
Abstract 1953: Accelerating prediction of pediatric and rare cancer vulnerabilities using next-generation cancer models
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors
Integrated genetic and pharmacologic interrogation of rare cancers
Abstract 4367: Accelerating prediction of tumor vulnerabilities using next-generation cancer models